Neurocrine Biosciences (NBIX): are the analysts right?

Neurocrine Biosciences · Health Care · ref. ETF XLV · 123 calls · price $170.19
What the company does: Neurocrine Biosciences découvre et commercialise des produits pharmaceutiques pour troubles neurologiques et psychiatriques.
📈 1-year price
$177.49+37.9% over range
Jul 8, 25low $123.1 · high $177.49Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
88% recommend buying · 17 analysts

🎯 Analyst price target on NBIX

High target · 1 analyst$246+44.5%
Median target · 17 analysts$183+7.5%
Low target · 1 analyst$140-17.7%
Current price$170.19

🗳️ The analyst consensus

Analyst breakdown · 17 (6 months)
Strong Buy0%
Buy88%
Hold12%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on NBIX

Most reliable analysts on NBIX (% profitable · 365j · ≥2 calls)
Canaccord Genuity 67% +12.8% 12
Wedbush 67% +5.8% 9
HC Wainwright & Co. 67% +4.4% 12
Guggenheim 60% +10.1% 5
Oppenheimer 50% +11.7% 12
Cantor Fitzgerald 50% +1.9% 10
JP Morgan 33% -3.1% 12

📊 What $1,000 invested in Neurocrine Biosciences would be worth

In short — $1,000 invested in Neurocrine Biosciences 10 years ago would be worth $2,979 today, i.e. +12%/yr on average. Best year: 2017 (+100%), worst: 2016 (-32%). Price performance, excluding dividends.

If I'd invested $1,000 in Neurocrine Biosciences

InvestmentWorth todayGain
1 years ago$1,235+23%
3 years ago$1,411+41%
5 years ago$1,758+76%
10 years ago$2,979+198%
since inception (1996)$18,990+1799%

Return by year (Neurocrine Biosciences)

YearReturn$1,000 invested at year start
2026 (YTD)+19%$1,188 (+19%)
2025+4%$1,235 (+23%)
2024+4%$1,279 (+28%)
2023+10%$1,411 (+41%)
2022+40%$1,979 (+98%)
2021-11%$1,758 (+76%)
2020-11%$1,568 (+57%)
2019+51%$2,360 (+136%)
2018-8%$2,172 (+117%)
2017+100%$4,355 (+335%)
2016-32%$2,979 (+198%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on NBIX

RBC Capital
May 29, 26
▲ Outperform · 🎯$183
Price at call : $161 — upside +14%
Today : $170.19 — upside +8%
🎯 on NBIX : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : May 29, 27
Bernstein
May 22, 26
▲ Outperform · 🎯$221
Price at call : $155.73 — upside +42%
Today : $170.19 — upside +30%
🎯 on NBIX : no call matured yet · 📊 on Health : 60% · +5.1% (5 calls)
in progress (365j)
matures : May 22, 27
JP Morgan
May 8, 26
▲ Overweight · 🎯$185
Price at call : $150.59 — upside +23%
Today : $170.19 — upside +9%
🎯 on NBIX : 33% (12 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : May 8, 27
▲ Buy · 🎯$155
Price at call : $152.25 — upside +2%
Today : $170.19 — upside -9%
🎯 on NBIX : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : May 7, 27
Citigroup
May 6, 26
▲ Buy · 🎯$246
Price at call : $149.59 — upside +64%
Today : $170.19 — upside +45%
🎯 on NBIX : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 6, 27
■ Equal-Weight neutral · not a buy · 🎯$191
Price at call : $149.59 — gap to target +28%
Today : $170.19 — gap to target +12%
🎯 on NBIX : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : May 6, 27
RBC Capital
May 6, 26
▲ Outperform · 🎯$180
Price at call : $149.59 — upside +20%
Today : $170.19 — upside +6%
🎯 on NBIX : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : May 6, 27
▲ Overweight · 🎯$207
Price at call : $149.59 — upside +38%
Today : $170.19 — upside +22%
🎯 on NBIX : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : May 6, 27
Guggenheim
May 6, 26
▲ Buy · 🎯$175
Price at call : $149.59 — upside +17%
Today : $170.19 — upside +3%
🎯 on NBIX : 60% (5 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : May 6, 27
Wedbush
May 6, 26
▲ Outperform · 🎯$176
Price at call : $147.02 — upside +20%
Today : $170.19 — upside +3%
🎯 on NBIX : 67% (9 calls matureds) · 📊 on Health : 40% · +1.1% (30 calls)
in progress (365j)
matures : May 6, 27
▲ Outperform · 🎯$170
Price at call : $130.19 — upside +31%
Today : $170.19 — upside -0%
🎯 on NBIX : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Apr 22, 27
■ Equal-Weight neutral · not a buy · 🎯$185
Price at call : $126.32 — gap to target +46%
Today : $170.19 — gap to target +9%
🎯 on NBIX : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Apr 10, 27
Citigroup
Apr 7, 26
▲ Buy · 🎯$242
Price at call : $133.15 — upside +82%
Today : $170.19 — upside +42%
🎯 on NBIX : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Apr 7, 27
▲ Buy · 🎯$200
Price at call : $133.15 — upside +50%
Today : $170.19 — upside +18%
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Apr 7, 27
Wedbush
Apr 7, 26
▲ Outperform · 🎯$166
Price at call : $130.9 — upside +27%
Today : $170.19 — upside -2%
🎯 on NBIX : 67% (9 calls matureds) · 📊 on Health : 40% · +1.1% (30 calls)
in progress (365j)
matures : Apr 7, 27
▲ Buy · 🎯$215
Price at call : $130.9 — upside +64%
Today : $170.19 — upside +26%
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Apr 7, 27
Needham
Apr 6, 26
▲ Buy · 🎯$185
Price at call : $130.9 — upside +41%
Today : $170.19 — upside +9%
🎯 on NBIX : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Apr 6, 27
JP Morgan
Mar 12, 26
▲ Overweight · 🎯$177
Price at call : $129.78 — upside +36%
Today : $170.19 — upside +4%
🎯 on NBIX : 33% (12 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Mar 12, 27
▲ Outperform · 🎯$160
Price at call : $130.96 — upside +22%
Today : $170.19 — upside -6%
🎯 on NBIX : no call matured yet · 📊 on Health : 46.2% · +2.9% (13 calls)
in progress (365j)
matures : Feb 24, 27
JP Morgan
Feb 17, 26
▲ Overweight · 🎯$176
Price at call : $128.38 — upside +37%
Today : $170.19 — upside +3%
🎯 on NBIX : 33% (12 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Feb 17, 27
▲ Buy · 🎯$140
Price at call : $128.38 — upside +9%
Today : $170.19 — upside -18%
🎯 on NBIX : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Feb 17, 27
Wells Fargo
Feb 13, 26
▲ Overweight · 🎯$175
Price at call : $127.76 — upside +37%
Today : $170.19 — upside +3%
🎯 on NBIX : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 13, 27
Citigroup
Feb 12, 26
▲ Buy · 🎯$204
Price at call : $124.12 — upside +64%
Today : $170.19 — upside +20%
🎯 on NBIX : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Feb 12, 27
RBC Capital
Feb 12, 26
▲ Outperform · 🎯$177
Price at call : $124.12 — upside +43%
Today : $170.19 — upside +4%
🎯 on NBIX : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Feb 12, 27
BMO Capital
Feb 12, 26
■ Market Perform neutral · not a buy · 🎯$140
Price at call : $124.12 — gap to target +13%
Today : $170.19 — gap to target -18%
🎯 on NBIX : no call matured yet · 📊 on Health : 41.9% · +5.4% (31 calls)
in progress (365j)
matures : Feb 12, 27
Wedbush
Feb 12, 26
▲ Outperform · 🎯$151
Price at call : $124.12 — upside +22%
Today : $170.19 — upside -11%
🎯 on NBIX : 67% (9 calls matureds) · 📊 on Health : 40% · +1.1% (30 calls)
in progress (365j)
matures : Feb 12, 27
▲ Buy · 🎯$192
Price at call : $123.1 — upside +56%
Today : $170.19 — upside +13%
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Feb 12, 27
Needham
Feb 12, 26
▲ Buy · 🎯$185
Price at call : $123.1 — upside +50%
Today : $170.19 — upside +9%
🎯 on NBIX : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Feb 12, 27
UBS
Jan 23, 26
▲ Buy · 🎯$178
Price at call : $134.51 — upside +32%
Today : $170.19 — upside +5%
🎯 on NBIX : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jan 23, 27
JP Morgan
Jan 12, 26
▲ Overweight · 🎯$177
Price at call : $132.26 — upside +34%
Today : $170.19 — upside +4%
🎯 on NBIX : 33% (12 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Jan 12, 27
▲ Buy · 🎯$169
Price at call : $135.79 — upside +24%
Today : $170.19 — upside -1%
🎯 on NBIX : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jan 8, 27
■ Equal-Weight neutral · not a buy · 🎯$175
Price at call : $135.57 — gap to target +29%
Today : $170.19 — gap to target +3%
🎯 on NBIX : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Jan 8, 27
▲ Buy · 🎯$198
Price at call : $141.7 — upside +40%
Today : $170.19 — upside +16%
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Dec 17, 26
Mizuho
Dec 12, 25
■ Neutral neutral · not a buy · 🎯$175
Price at call : $152.8 — gap to target +15%
Today : $170.19 — gap to target +3%
🎯 on NBIX : no call matured yet · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Dec 12, 26
Stifel
Dec 11, 25
▲ Buy · 🎯$188
Price at call : $154.75 — upside +21%
Today : $170.19 — upside +10%
🎯 on NBIX : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Dec 11, 26
RBC Capital
Dec 8, 25
▲ Outperform · 🎯$180
Price at call : $155.02 — upside +16%
Today : $170.19 — upside +6%
🎯 on NBIX : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Dec 8, 26
TD Cowen
Dec 5, 25
▲ Buy · 🎯$200
Price at call : $154.99 — upside +29%
Today : $170.19 — upside +18%
🎯 on NBIX : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Dec 5, 26
▲ Overweight · 🎯$173
Price at call : $147.29 — upside +17%
Today : $170.19 — upside +2%
🎯 on NBIX : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Nov 11, 26
JP Morgan
Nov 3, 25
▲ Overweight · 🎯$179
Price at call : $143.19 — upside +25%
Today : $170.19 — upside +5%
🎯 on NBIX : 33% (12 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Nov 3, 26
▲ Buy · 🎯$172
Price at call : $138.04 — upside +25%
Today : $170.19 — upside +1%
🎯 on NBIX : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Oct 30, 26
▲ Buy · 🎯$164
Price at call : $138.04 — upside +19%
Today : $170.19 — upside -4%
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Oct 29, 26
Citigroup
Oct 29, 25
▲ Buy · 🎯$203
Price at call : $138.04 — upside +47%
Today : $170.19 — upside +19%
🎯 on NBIX : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Oct 29, 26
Stifel
Oct 29, 25
▲ Buy · 🎯$183
Price at call : $138.04 — upside +33%
Today : $170.19 — upside +8%
🎯 on NBIX : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Oct 29, 26
RBC Capital
Oct 29, 25
▲ Outperform · 🎯$160
Price at call : $138.04 — upside +16%
Today : $170.19 — upside -6%
🎯 on NBIX : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Oct 29, 26
Piper Sandler
Oct 29, 25
▲ Overweight · 🎯$179
Price at call : $138.02 — upside +30%
Today : $170.19 — upside +5%
🎯 on NBIX : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Oct 29, 26
Needham
Oct 29, 25
▲ Buy · 🎯$184
Price at call : $138.02 — upside +33%
Today : $170.19 — upside +8%
🎯 on NBIX : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Oct 29, 26
Citigroup
Oct 21, 25
▲ Buy · 🎯$175
Price at call : $142.65 — upside +23%
Today : $170.19 — upside +3%
🎯 on NBIX : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Oct 21, 26
▲ Overweight · 🎯$168
Price at call : $142.65 — upside +18%
Today : $170.19 — upside -1%
🎯 on NBIX : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Oct 20, 26
UBS
Oct 9, 25
▲ Buy · 🎯$195
Price at call : $136.63 — upside +43%
Today : $170.19 — upside +15%
🎯 on NBIX : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Oct 9, 26
Needham
Sep 22, 25
▲ Buy · 🎯$170
Price at call : $146.62 — upside +16%
Today : $170.19 — upside -0%
🎯 on NBIX : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Sep 22, 26
Wedbush
Jul 31, 25
▲ Outperform · 🎯$141
Price at call : $128.23 — upside +10%
Today : $170.19 — upside -17%
🎯 on NBIX : 67% (9 calls matureds) · 📊 on Health : 40% · +1.1% (30 calls)
in progress (365j)
matures : Jul 31, 26
Guggenheim
May 6, 25
▲ Buy · 🎯$165
Price at call : $121.61 — upside +36%
Today : $170.19 — upside -3%
Expected +36% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on NBIX : 60% (5 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+23.0%
stock +23% · XLV +7%
▲ Buy · 🎯$160
Price at call : $118.92 — upside +35%
Today : $170.19 — upside -6%
Expected +35% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
+23.6%
stock +24% · XLV +8%
▲ Buy · 🎯$158
Price at call : $106.46 — upside +48%
Today : $170.19 — upside -7%
Expected +48% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
+20.3%
stock +20% · XLV +4%
▲ Buy · 🎯$168
Price at call : $101.74 — upside +65%
Today : $170.19 — upside -1%
Expected +65% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+28.9%
stock +29% · XLV +8%
▲ Buy · 🎯$185
Price at call : $119.11 — upside +55%
Today : $170.19 — upside +9%
Expected +55% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+10.0%
stock +10% · XLV +7%
▲ Buy · 🎯$185
Price at call : $120.69 — upside +53%
Today : $170.19 — upside +9%
Expected +53% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+6.4%
stock +6% · XLV +8%
Guggenheim
Feb 10, 25
▲ Buy · 🎯$163
Price at call : $118.81 — upside +37%
Today : $170.19 — upside -4%
Expected +37% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on NBIX : 60% (5 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+15.9%
stock +16% · XLV +6%
▲ Buy · 🎯$185
Price at call : $118.81 — upside +56%
Today : $170.19 — upside +9%
Expected +56% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on NBIX : 67% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+15.9%
stock +16% · XLV +6%
Wedbush
Feb 7, 25
▲ Outperform · 🎯$147
Price at call : $118.81 — upside +24%
Today : $170.19 — upside -14%
Expected +24% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on NBIX : 67% (9 calls matureds) · 📊 on Health : 40% · +1.1% (30 calls)
+17.5%
stock +17% · XLV +7%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)